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Abstract
Hypoglycemia (low blood glucose level) is a medical emergency and is a very common in type 1
diabetic persons and can occur at any age. It is the major limiting factor to maintain tight glycemic
control. The deficiency in glucose counter-regulation may even lead to severe hypoglycaemia. It is
always threatening to the well-being of patients with Type 1 diabetes mellitus (T1DM) since more severe
hypoglycemia leads to seizures or loss of consciousness and the possible development of permanent
brain dysfunction under certain circumstances . Because of that, an accurate continuing hypoglycemia
monitoring system is a very important medical device for diabetic patients. Traditionally, different
electrochemical glucose meters are adopted to measure the blood glucose. However, they are invasive,
discontinuing and uncomfortable methods or painful for patients. In this paper, we proposed a non-
invasive hypoglycemia monitoring system using the physiological parameters of electrocardiography
(ECG) signal such as heart rate and corrected QT intervals. To enhance the detection accuracy of
the hypoglycemia, a new emerging technology called extreme learning machine (ELM) is developed
to recognize the presence of hypoglycemic episodes. ELM have both universal approximation and
classification capabilities and provides efficient unified solutions to generalize feed-forward neural
networks. A real clinical study of sixteen children with T1DM are given in this paper to illustrate
the performance of ELM and successfully applied to a non-invasive hypoglycemia monitoring system.
The natural occurrence of nocturnal hypoglycemic episodes are associated with increased heart rates
(p< 0:06) and increased corrected QT intervals (p< 0:001). For comparison purpose, different compu-
tational intelligence technologies such as swarm based neural network, multiple regression based-fuzzy
inference system, and fuzzy system were applied to this hypoglycemia monitoring system. By using the
proposed ELM-based neural network (ELM-NN), the testing sensitivity (true positive) and specificity
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(true negative) for detection of hypoglycemia is better than the other intelligence methods with faster
training time.
I. INTRODUCTION
Type 1 diabetes usually arises in children or young adults and is characterized by the inability
to produce insulin. Although treatment regimens and types of insulin available have developed
over time, individuals with type 1 diabetes are still required to self inject with insulin to control
their blood glucose levels. Insulin doses must be adjusted according to carbohydrate intake and
the degree of physical activity being undertaken.
For patients with type 1 diabetes, hypoglycemia (low blood glucose level) is one of the most
common side effects and it is well know as a barrier for achieving and maintaining tight glycemic
control. Individuals who experience frequent episodes of hypoglycemia and those who have been
on insulin therapy for a long period of time may develop impaired awareness of hypoglycemia.
Impaired hypoglycaemic awareness occurs in approximately 25% of individuals with type 1
diabetes. Severe hypoglycemia may lead to physical and psychosocial morbidities such as brain
damage, loss of consciousness, depression and low self-esteem [1]. It is also well known as
death-in-bed syndrome [2].
Firstly, hypoglycemia is literally translated as a state produced by a lower level of blood
glucose. It represents a significant hazard in patients with Type 1 diabetes mellitus (T1DM)
which is a chronic medical condition that occurs when the pancreas produces very little or no
insulin. In [3], another definition is given to hypoglycemia as the occurrence of a wide variety
of symptoms in association with a plasma glucose concentration of 50 mg/dl or less. In clinical
studies [4], the events of hypoglycemia are classified ranging from mild to severe level after
reviewing the background of hypoglycemia. Most surveys revealed that the tighter the glycemic
control in the younger patient, the greater frequency of both mild and severe hypoglycemia [5].
The level of blood glucose low enough to define hypoglycemia may be different for different
people, in different circumstances, and for different purposes and occasionally has been a matter
of controversy. Most healthy adults maintain fasting glucose levels above 3.9 mmol/l (70 mg/dl),
and develop symptoms of hypoglycemia when the glucose level falls below 3.0 mmol/l (55
mg/dl). In [6], it has been reported that the severe hypoglycaemic episodes are defined in those
whose documented blood glucose levels is 2.8 mmol/l (50mg/dl) and the patient are advised to
take necessary treatment. In this paper, blood glucose levels less than 3.33 mmol/l (60 mg/dl)
are considered as hypoglycemic episodes [6].
Several research works have been reported where patients with type 1 diabetes have been
found dead in an undisturbed bed [2]. Since hypoglycemia can occur at any age due to many
different conditions, early detection and prevention of hypoglycemia is more important for
diabetes patients. To prevent or minimize hypoglycemic morbidities and mortalities, it is vital to
return the blood glucose level to normal soon after a hypoglycemic event occurs. The patients’
conditions are obviously need to know; when the event of hypoglycemia is initiated, and/or how
the early warning is detected [7]. In other words, the need for hypoglycemia monitoring device
is very important to provide an alarm alert to type 1 diabetes patients or carer when low blood
glucose level is detected.
Real-time continuous glucose monitoring has the potential to overcome diabetic complications
and increase the likelihood of patients with diabetes by maintaining optimal glucose level without
symptomatic hypoglycemia. In clinical practice recommendations, it has also been suggested
that continuous glucose monitoring is especially useful in patients with type 1 diabetes in
order to detect hypoglycemia unawareness and/or frequent episodes of hypoglycemia. With
ever improving advances in diabetes diagnostic technology, different blood glucose monitoring
systems, invasive, minimally invasive and non-invasive are tested and introduced by the use of
various techniques with the choice of sample region as described in Fig. 1.
Minimally invasive devices [8] or non-invasive devices [9] have been tested and introduced
with the aid of current technologies such as reverse iontophoresis, suction effusion fluid and near-
infrared spectroscopy. But they suffer from limitations in terms of measurement inaccuracy, high
susceptibility to artefact noise, considerable time delays for obtaining results, uncomfortableness
and long-term reproducibility. Also, the cost of strip and the boredom of making repeated
measurements become the great barriers for Type 1 diabetic patients who frequently need to
monitor their BGL as well as episodes of hypoglycemia. Sometimes, the manual monitoring of
blood glucose increases the risk of severe hypoglycemia due to their low efficiency in detecting
frequent episodes of hypoglycemia. To overcome the limitations of the invasive devices, non-
invasive continuing hypoglycemic monitoring systems have been developed.
The development of non-invasive continuous glucose monitoring systems is the only way for
achieving painless control of blood glucose level and improving life quality of diabetes patients
with better regulation of hypoglycemia episodes. To achieve it, hypoglycemia monitoring systems
have been investigated by the use of physiological parameters that are stimulated by falling blood
glucose levels. For instance, Teledyne Sleep Sentry [10] and Abbott Freestyle Navigator CGMS
[11].
Recently, computational intelligence technologies were investigated for non-invasive hypo-
glycemia monitoring system. Based on the highly correlation between physiological parameters
and hypoglycemia, a non-invasive hypoglycemia monitor was tested and introduced by Nguyen
et al. [12] [13]. This system is employed by Bayesian neural network algorithm and the physio-
logical parameters such as heart rate (HR), corrected QT interval (QTc) and skin impedance are
used. The sensitivity of this device was found to be satisfactory, but the specificity need to be
improved. More advanced neural network algorithms are still needed for obtaining better testing
sensitivity and specificity. In addition, fuzzy estimator [14], fuzzy neural network estimator [15]
were proposed for hypoglycemia detection systems. In these systems, the status of hypoglycemia
was predicted through the changes in physiological parameters of the ECG signal. However, the
membership functions which express the linguistic terms for fuzzy inference rules have to be
defined. In practise, there is no formal approach for defining these rules and the optimization
of these membership functions in terms of generalizing the data is also very important. Usually,
tuning parameters of membership function is a time consuming task.
In [16] [17], an evolved fuzzy reasoning model was developed to recognize the presence of
hypoglycemic episodes. The physiological parameters such as heart rate and corrected QT interval
of ECG signal were continuously measured for early detection of hypoglycemic episodes in Type
1 diabetes mellitus (T1DM) patients. In this method, the fuzzy rules and fuzzy membership
functions were optimized by hybrid particle swarm optimization with wavelet mutation. The
results showed that the proposed algorithm performed well in terms of the sensitivity and
specificity. However, more parameters were need to be optimized and a large computational
time is need for training. Further experiment were conducted by the use of neural network based
rule discovery system [18]. The development was based on 420 data sets which were collected
from 16 T1DM patients by using the genetic algorithm. Though the obtained sensitivity and
specificity are reasonable, the neural network used in the developed detection system might not
be able to improve further because its slow learning speed and poor computational scalability.
To overcome the challenges faced by the mentioned state-of-the-art computational intelligence
techniques, an emerging new technique named extreme learning machine (ELM) [19] has been
brought to the considerable attention. In this paper, ELM is used to train a single-hidden layer
feed-forward neural network (FFNN) and used to detect the status of hypoglycemia. Different
from common understanding of learning algorithm for FFNN, its hidden node parameters are
randomly generated and no tuning process is necessary. Besides, it is able to achieve the smallest
training error as well as the smallest norm of output weights. Due to its significant features
including faster learning speed and better generalization, ELM-based hypoglycemia monitoring
system is investigated in this paper. To illustrate the performance of the proposed ELM based
hypoglycemia monitoring system, a study of 16 T1DM children with 589 sampled data is given
and found that the proposed method is successful in detecting nocturnal hypoglycemic episodes
with faster learning time.
This paper is organized as follows: in Section II, details of the development of feed-forward
neural network and extreme learning machine are introduced. To show the effectiveness of our
proposed methods, the results of the detection of nocturnal hypoglycaemia episodes in T1DM
are discussed in Section III and a conclusion is drawn in Section IV.
Fig. 1. Overview of technologies for blood glucose control: invasive, minimally invasive and non-invasive [Amaral2008]
II. METHODS
To realize the detection of hypoglycemic episodes in T1DM patients, an ELM-based neural
network is developed with four physiological parameters of ECG inputs and one output, as
shown in Fig. 2. The four physiological parameters of ECG are heart rate (HR), corrected QT
interval of ECG (QTc), change of heart rate (D HR), and change of corrected QT interval of
ECG (D QTc), while output is the onset of hypoglycemia, +1 representing non-hypoglycemia
and -1 representing hypoglycemia. The ELM-based neural network plays a important role in
modeling the correlation between the four physiological parameters of ECG and the onset of
hypoglycemia. For patient with type1 diabetes, the possibility of hypoglycemia is mainly effected
by prolongation of QT intervals (starting from the point of Q wave to at the end of T wave)
and its correlation to heart rate. Not only QTc interval prolongation has a significant impact on
hypoglycemia, an increasing heart rate (HR) also may influence the onset of hypoglycemia.
Fig. 2. ELM-based neural network for hypoglycemia monitoring system
A. Electrocardiography (ECG)
Hypoglycemia has long been known to affect the electrocardiogram (ECG) causing ST wave
changes with lengthening of the QT interval and cardiac repolarization. These changes may
increase the risk of cardiac arrhythmia; various abnormal heart rhythms, including ventricular
tachycardia and atrial fibrillation [20]. These alternations are reflected by variations of ECG
parameters, Q point, R peak and T wave peak including the commonly used QT interval
(depolarization of the ventricles) which is the time taken from the start of the QRS complex to
the end of the T wave (repolarization of ventricles) as presented in Fig. 3.
A number of studies have been carried out on the prolongation of QTc interval under both
hyperinsulinemic hypoglycemia and spontaneous hypoglycemia and both conditions confirmed
that QTc dispersion is increased in healthy individuals and in patients with type 1 [21].
The obtained results indicated that the degree of QTc lengthening during clamped hypo-
glycemia (583 ms) was greater compared to the euglycaemic control period (429 ms) with
p < 0:001. An example of QT measurement from one subject under euglycaemia and hypo-
glycemia was given in Fig. 4 in which the QT intervals were marked using an on screen cursor
by two independent observers. As can be seen in Fig. 4, the increase in heart rate can cause
a reduction in the QT interval and the QT interval is corrected for differences in heart rate by
Bazett correction, dividing QT by the square root of RR, (QTc = QT/
p
RR) [22]. Not only QTc
interval prolongation has a significant impact on hypoglycemia, but an increase in heart rate
(HR) also may influence the onset of hypoglycemia.
Fig. 3. ECG Signal
A summary of the mean QTc lengthening during hypoglycemia [23], [24], [25], [26], [27],
[28], [29] is shown in Table. I. It can be distantly seen that all the techniques produce a
highly significant change of QTc for euglycemia and hypoglycemia conditions. Hence, the QTc
prolongation during nocturnal hypoglycemia is of clinical interest importance because it may
contribute to sudden death.
TABLE I
STUDIES OF CHANGES IN QTC DURING EUGLYCEMIC AND HYPOGLYCEMIC STUDIES
Euglycemia Hypoglycemia
Subjects QTc (ms) DQTc
(ms)
QTc (ms) DQTc
(ms)
8 T1DM and 7 Healthy [23] 429 18 583 162
10 Healthy [24] 400 20 450 70
17 Healthy [25] 406 16 480 90
8 T1DM [26] 407 16 448 57
17 Healthy [27] 399 7 459 67
16 T1DM and 8 Healthy [28] 410 10 419 13
18 Healthy [29] 408 9 429 30
Based on the above founding, we selected heart rate (HR), corrected QT interval (QTc), change
of HR (DHR) and change of QTc (DQTc) as the inputs of the hypoglycemia monitoring system
and the hypo detection will be done by ELM-based neural network.
B. Extreme Learning Machine (ELM)-based neural network
In this section, extreme learning machine (ELM) for the training of single hidden layer
feedforward neural network (FFNN) in Fig. 5 is presented. Compared with the conventional
neural network learning algorithms, it can achieve faster training performance and overcome the
problem of over-fitting. The algorithm is based on the empirical risk minimization theory. Its
learning process needs only for a single iteration and is able to avoid multiple iterations and
local minimization. Because of better generalization ability, robustness, and controllability and
faster learning process, it has been used in many real world applications [30]. For N arbitrary
distinct samples (xi; ti) 2 Rd Rm, where x denotes the system inputs and t denotes the target
Fig. 4. Typical QT measurement with on screen cursor placement from one subject during euglycemia: (a) showing a clearly
defined T wave (b) showing prolonged repolarization [23].
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Fig. 5. Feed-forward neural network with single hidden layer
output. The mathematically model of FFNN with L hidden nodes can be written as:
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H is called the hidden layer output matrix of the FFNN, the ith column of H is the ith hidden
node output with respect to inputs x1;x2; : : : ;xN , h(x) = G(a1;b1;x) : : :G(aL;bL;x) is called as
the hidden layer feature mapping. From the interpolation capability point of view, if the activation
function G is infinitely differentiable in any interval the hidden layer parameters can be randomly
generated [19]. It means that the hidden layer output matrix H in (3) is initialized with random
weight (ai) and bias (bi) and calculate the output weight matrix b from the linear equation in
(2) by:
b = H†T (5)
where H† is the Moore-Penrose generalized inverse of the matrix H. To obtain H†, the orthogonal
projection method can be efficiently used, whereas H†=
 
HTH
 1HT (or) H†=HT HHT 1 if
HTH and HHT are nonsingular. Substituting the output weight matrix in (1) to (5) and calculate
the corresponding output of FFNN. The proposed hypoglycemia detection system, FFNN trained
by ELM algorithm is given in detail as follows:
1) The hidden node parameters, (ai;bi), i= 1; : : : ;L are randomly generated.
2) The hidden layer output matrix H in (3) is calculated.
3) Obtain the output weight vector b in (5) by b =
 
HTH
 1HTT (or)  HHT 1HTT .
4) The output of FFNN , y is calculated by (1) and it is defined as positive when the status
of hypoglycemia h is positive which expressed as:
h=
8<: +1; y 0 1; y< 0 :
According to conventional neural network theories, hidden layer parameters, ie., weight and
biases (ai and bi) and the output weights bi need to be tuned properly and searching for optimal
parameters. Much efforts have been tried for obtaining better way of finding and adjusting hidden
layer parameters (ai;bi). In [31], incremental learning method which mainly focus and adjust on
the newly added hidden nodes rather than adjusting all the hidden nodes parameters. In contrast,
all the parameters of FFNN such as weight (ai) and biases (bi) and the output weight parameters
(bi) need not be tuned and can be independent of training samples.
Similar to the conventional neural network, the numbers of hidden nodes are chosen by trial
and error method until the optimal solution is obtained. However, there is a trade-off between too
less number and too many numbers of hidden nodes because less number of node is insufficient to
give the optimal solution and more numbers may unnecessarily increase the number of parameters
to be tuned by ELM.
In essence, the ELM is not necessary to be tuned iteratively. Both the training error and the
norm of weight can be minimized as long as the hidden layer feature mapping need to satisfy
approximation condition [32]. In ELM, the hidden nodes can be randomly generated and the
output weights vector bi is the only unknown parameters which can be resolved by ordinary least-
square directly. Unlike the traditional computational intelligence techniques, ELM also provide
better generalization performance at a much faster convergence rate.
III. CLINICAL STUDY: RESULTS AND DISCUSSIONS
In this paper, clinical study with different computational intelligence technologies are pre-
sented and discussed. Sixteen children with T1DM (14.6  1.5 years) volunteered for the 10-
hour overnight hypoglycemia study at the Princess Margaret Hospital for Children in Perth,
Western Australia. Each patient is monitored overnight for the natural occurrence of nocturnal
hypoglycemia. Data were collected with approval from Women’s and Children’s Health Service,
Department of Heath, Government of Western Australia, and with informed consent.
We measured the required physiological parameters, while the actual blood glucose levels
were collected as reference using Yellow Spring Instruments. The main parameters used for the
detection of hypoglycemia are the heart rate and corrected QT interval. The actual blood glucose
profiles for 16 T1DM children are shown in Fig. 6. The duration approximately is 360 - 480
mins. All data points of the patients are start recorded at night. In effect, it estimates the presence
of hypoglycaemia at sample period ks based on the basic of the data at sampling period ks and
the previous data at sampling period ks 1. In general, the sampling period is 5-10 minutes and
approximately 35-40 data points are used for each patient. The responses from 16 T1DM children
exhibit significant changes during the hypoglycemia phase against the non-hypoglycemia phase.
Normalization is used to reduce patient-to-patient variability and to enable group comparison by
dividing the patient’s heart rate and corrected QT interval by his/her corresponding values at time
zero. The changes in HR and QTc were observed during the hypoglycemic event. In this group
of patients, compared to the observed data during non-hypoglycemic episodes, their normalized
heart rates (HR) increased (1:082 0:298 vs. 1:033 0:242, p < 0:06) and their normalized
corrected QT intervals (QTc) increased significantly (1:0600:0844 vs. 1:0310:086, p< 0:001)
during hypoglycemic episodes which was specified at 3.33 mmol/l [33]. These changes would
last as long as hypoglycemic episodes persist. However, after the glucose level recovered, these
changes in HR and QTc would be responded to normal within 5-10 minutes. For hypoglycemic
episodes, the normalized mean of HR and QTc are decreased from 1.1423 to 1.0250 and 1.0656
to 1.0030 respectively.
Among sixteen patients, 12 patients were found to experience hypoglycemic episodes as their
blood glycose level were less or equal than 3.33 mmol/l, while 4 patients did not experience
hypo events. Information for each patient in terms of number and duration of hypo events (BGL
 3.33mmol/l) is tabulated in Table II. Patient numbers 1-8 were used for training and patient
number 9-16 were used for testing. The patients number are randomly chosen from these 16
patients. With these 16 patients, the number of sampled data points for training and testing are
320 and 269 respectively.
To measure the performance of hypoglycemia monitoring system for clinical studies, Sensi-
tivity, x and Specificity, h are introduced [Altman1994]:
x =
NTP
NTP+NFN
; h =
NTN
NTN+NFP
(6)
where NTP is defined as number of true positive, NFN is number of false negative, NFP is
number of false positive, and NTN is number of true negative. In clinical studies, sensitivity is
more important than specificity because it identifies the actual hypoglycemic episodes in patients
with T1DM. Thus, higher sensitivity are essential.
For comparison and analysis purposes, five methods are investigated to the hypoglycemia
monitoring system as following:
1) Proposed ELM-based neural network(ELM-NN);
2) Particle swarm optimization based neural network(PSO-NN)[17];
3) Second order multiple regression fuzzy inference system (MR-FIS) [16];
4) Fuzzy inference system (FIS) [34];
5) Linear multiple regression (LMR).
For PSO-NN, a three-layer feed-forward neural network trained with hybrid particle swarm
optimization with wavelet mutation is used. The settings of the PSO parameters can be found in
[17]. For MR-FIS, a multiple regression with fuzzy inference system is applied to hypoglycemia
application, genetic algorithm is used to optimize the fuzzy rules and the regression model. FIS
and LMR are also applied to this application for comparison purpose. The number of membership
function for each input (total 4 inputs) of FIS is five and the total number of fuzzy rules is 625.
All of the methods are applied into the hypoglycemia monitoring system where the four inputs
of the system are heart rate (HR), QT interval (QTc), DHR and DQTc and one output to represent
the onset of hypoglycemia. The testing results in term of sensitivity, specificity, gamma value
are tabulated in Table III. Moreover, the training time for all methods are also shown in the same
table to illustrate how fast of the proposed method compared with other methods. In this table,
gamma (g) analysis is introduced in (7) to evaluate the actual performance of this biomedical
application. As mentioned, the performance of sensitivity is more important, thus, the ratio of
sensitivity and specificity is set to 60 : 40 (q = 0:6 for gamma analysis in (7) ).
g = qx +(1 q)h (7)
Fig. 6. Blood glucose level profiles for sixteen TIDM children
In Table III, we can seen that the testing sensitivity and specificity of the proposed ELM-NN
achieve 78.00 and 60.00 % which is better than MR-FIS (75.00 % and 50.23 % for testing
sensitivity and specificity) and FIS (75.00 % and 51.04 % for testing sensitivity and specificity).
In terms of gamma value, ELM-NN still performs better compared with other methods. To
illustrate the efficiency of ELM, PSO-NN is used to compare. PSO-NN has same neural network
structure of ELM-NN but trained with a hybrid PSO with wavelet mutation [17]. Given from
the results, it can be seen that the performance of the ELM-NN is outperformed in terms of
testing sensitivity, testing specificity, and gamma value. Besides, training time for all methods
are given in same table. We can seen that the proposed ELM-NN gives a faster training time
which is about 3 mins, while the other methods (PSO-NN, MR-FIS, and FIS) take around 30
to 275 mins. PSO-NN, trained by PSO and MR-FIS, and FIS are trained by genetic algorithm.
Both evolutionary algorithm are time consuming and take longer time for training especially
FIS involved 625 fuzzy rules need to be trained. LMR gives a very fast training time due to its
simple modeling and only few tuning parameters, however, the testing sensitivity is unacceptable
(51.78% only). In Summary, the ELM-NN gives better results with faster training time.
IV. CONCLUSIONS
In this paper, a non-invasive nocturnal hypoglycemia monitoring system for type 1 diabetes
patients using extreme learning machine-based neural network model is developed. The results
indicate that hypoglycemic episodes in type 1 diabetes mellitus children can be detected non-
invasively and continuously effectively from the real-time physiological responses (heart rate
and corrected QT interval). With the experimental result, which indicates that the proposed
extreme learning machine based neural work performs better testing sensitivity and specificity
with a faster training rate. As conclude, the testing performances of the proposed algorithm for
detection of hypoglycemic episodes (sensitivity is 78.00% and specificity is 60.00%) for T1DM
are satisfactory.
There are two main limitations for the proposed hypoglycemia monitoring system should be
considered. Firstly, all the data were recorded from children with type 1 diabetes and the age
range is 14.6  1.5 years. With these young people, there are no any heart problems to affect the
heart rate and QT interval and there are no confounding conditions including in these data set.
If the patients have heart problem where the detection performance accuracy may be affected.
Secondly, we assume that the normal resting heart rate for all patients meet the international
health association standard.
TABLE II
INFORMATION FOR EACH PATIENT IN TERMS OF NUMBER AND DURATION OF HYPOGLYCEMIA EVENTS FOR HYPOGLYCEMIC
EPISODES WHERE BGL  3.33 MMOL/L.
Patient number Number of hypo events Duration of events Patient number Number of hypo events Duration of events
1 0 0 min 9 17 105 mins
2 8 40 mins 10 0 0 min
3 7 45 mins 11 0 0 min
4 10 50 mins 12 9 45 mins
5 4 20 mins 13 9 85 mins
6 14 75 mins 14 13 70 mins
7 9 45 mins 15 7 70 mins
8 11 55 mins 16 0 0 min
TABLE III
TESTING RESULTS AND TRAINING TIME
Algorithms Sensitivity Specificity gamma value (g) Training time
ELM-NN 78.00% 60.00% 70.80% 3 mins
PSO-NN 63.64% 54.67% 60.05% 30 mins
MR-FIS 75.00% 50.23% 65.09% 40 mins
FIS 75.00% 51.64% 66.55% 275 mins
LMR 51.78% 51.64% 51.72% 1 min
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